Publication & Citation Trends
Publications
0 total
270P First-line cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in patients with a homologous recombination repair (HRR) germline pathogenic variant (PV) and breast cancer (BC): Clinical outcomes and mechanisms of resistance
Cited by 2
Semantic Scholar
154P Characteristics and outcomes of young BRCA carriers with triple-negative breast cancer (TNBC) according to histology subtype
Cited by 0
Semantic Scholar
Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors
Cited by 0
Semantic Scholar
416O Safety of having a subsequent pregnancy after a prior diagnosis of breast cancer during pregnancy (PrBC) in young BRCA carriers
Cited by 1
Semantic Scholar
260P LUZERN: Phase II trial of niraparib and aromatase inhibitors (AI) for pretreated hormone receptor-positive/HER2-negative germline BRCA-mutated advanced breast cancer OA
Cited by 2
Semantic Scholar
166P Clinical use of tumor sequencing for identification of germline pathogenic variants (gPV) in breast cancer (BC): The SEQ project OA
Cited by 0
Semantic Scholar
179O Combination of olaparib, durvalumab and fulvestrant in patients with advanced ER-positive, HER2-negative breast cancer harboring homologous recombination repair (HRR) deficiency or microsatellite instability (MSI): Results of the international phase II DOLAF trial OA
Cited by 6
Semantic Scholar
Research Topics
BRCA gene mutations in cancer
(3)
PARP inhibition in cancer therapy
(3)
Breast Cancer Treatment Studies
(1)
Prostate Cancer Treatment and Research
(1)
Ovarian cancer diagnosis and treatment
(1)
Affiliations
Vall d'Hebron Hospital Universitari
Complexo Hospitalario Universitario A Coruña
Vall d'Hebron Institute of Oncology